Frequency and Patterns of Psychiatric Comorbidity in a Sample of Primary Care Patients with Anxiety Disorders

Comprehensive Psychiatry

Volumn 45, Issue 2, 2004, Pages 129-137

  Rodriguez, Benjamin F ^a   Weisberg, Risa B ^b   Pagano, Maria E ^b   Machan, Jason T ^b   Culpepper, Larry ^b   Keller, Martin B ^b  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MOOD DISORDER; PRIMARY MEDICAL CARE; PSYCHIATRIC DIAGNOSIS;

EID: 1542513951     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2003.09.005     Document Type: Article

References (38)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Psychol Med 1994;29:555-567.
2. Kessler RC, Nelson CB, McGonagle KA, Lui J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the National Comorbidity Survey. Br J Psychiatry 1996;168:17-30.
3. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-321.
4. Kessler RC, Stang PE, Wittchen HU, Ustan TB, Roy-Byrne PP, Walters EE. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 1998;55:801-808.
5. Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AE Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998;173(34 Suppl):24-28.
6. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol 1992;6:835-844.
7. Goisman RM, Goldenberg I, Vasile RG, Keller MB. Comorbidity of anxiety disorders in a multicenter anxiety study. Compr Psychiatry 1995;36:303-311.
8. Sanderson WC, DiNardo PA, Rapee RM, Barlow DH. Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J Abnorm Psychol 1990;99:308-312.
9. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts et al. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry 1993;150:1216-1218.
10. Massion AO, Warshaw MG, Keller MB. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993;150:600-607.
11. Andrews G. Comorbidity in neurotic disorders: The similarities are more important than the differences. In: Rapee RM (ed). Current Controversies in the Anxiety Disorders. New York, NY: Guilford Press, 1993:3-20.
12. Clark LA, Watson D, Reynolds S. Diagnosis and classification of psychopathology: challenges to the current system and future directions. Annu Rev Psychol 1995;46:121-153.
13. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991;100:316-336.
14. Emmanuel J, Simmonds S, Tyrer P. Systematic review of the outcome of anxiety and depressive disorders. Br J Psychiatry 1998;173(34 Suppl):35-41.
15. Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancil RB. Current and lifetime comorbidity of DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 2001;110:585-599.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Ed. 4. Washington, DC: APA, 1994.
17. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946;2:47-53.
18. Weillier E, Brisserbe JC, Maier W, Lecrubier Y. Prevalence and recognition of anxiety syndromes in five European primary care settings: a report from the WHO study on Pathological Problems in General Health Care. Br J Psychiatry 1998;173(34 Suppl):18-23.
19. Fifer SK, Mathias SD, Patrick DL, Mazonson PD, Lubeck DP, Buesching DP. Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 1994;51:740-750.
20. Leon AC, Olfson M, Portera L. Service utilization and expenditures for the treatment of panic disorder. Gen Hosp Psychiatry 1997;19:82-88.
21. Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 1998;173(34 Suppl):4-9.
22. Simon G, Ormel J, VonKorff M, Barlow W. Healthcare costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995;152:352-356.
23. Nisenson LG, Pepper CM, Schwenk TL, Coyne JC. The nature and prevalence of anxiety disorders in primary care. Gen Hosp Psychiatry 1998;20:21-28.
24. Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1756.
25. Zajecka J. Importance of establishing the diagnosis of persistent anxiety. J Clin Psychiatry 1997;58(3 Suppl):9-13.
26. Zimmerman M, Mattia JI. Psychiatric diagnosis in clinical practice: is comorbidity being missed? Compr Psychiatry 1999;40:182-191.
27. Zimmerman M, Mattia JI. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatr Serv 2000;51:1299-1304.
28. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for the DSM-IV Axis I Disorders. New York, NY: Biometrics Research Department, New York State Psychiatric Institute, 1996.
29. First MB, Gibbon M, Williams JBW, Spitzer RL. User's Guide for the Structured Clinical Interview for the DSM-IV Axis I Disorders-Research Version. New York, NY: Biometrics Research Department, New York State Psychiatric Institute, 1996.
30. First MB, Gibbon M, Williams JBW, Spitzer RL. SCID-101: Instructional Videotapes for SCID for DSM-IV. New York, NY: Biometrics Research Department, New York State Psychiatric Institute, 1996.
31. Maki KM, Weisberg RB, Machan JT, Keller MB. Treatments received for social anxiety disorder in a primary care setting. Poster presented at the annual meeting of the Anxiety Disorders Association of America, Austin, TX, March 2002.
32. Weisberg RB, Culpepper L, Keller MB. The underutilization of cognitive-behavioral therapy techniques in a sample of primary care patients with anxiety disorders. Presented at the Association for Advancement of Behavior Therapy Annual Conference, Philadelphia, PA, November 2001.
33. Kennedy BL, Schwab JJ. Utilization of medical specialists by anxiety disorder patients. Psychosomatics 1997;38:109-112.
34. Price D, Beck A, Nimmer C, Bensen S. The treatment of anxiety disorders in a primary care HMO setting. Psychiatr Q 2000;71:31-45.
35. Roy-Byrne PP, Stein MB, Russo J, Mercier E, Thomas R, McQuaid J, et al. Panic disorder in the primary care setting: Comorbidity, disability, service utilization, and treatment. J Clin Psychiatry 1999;60:492-499.
36. Lilienfeld SO, Turner SM, Jacob RG. Anxiety sensitivity: an examination of theoretical and methodological issues. Adv Behav Res Ther 1993;15:147-183.
37. Reiss S. Expectancy model of fear, anxiety, and panic. Clin Psychol Rev 1991;11:141-153.
38. Reiss S, Havercamp SH. The sensitivity theory of motivation: implications for psychopathology. Behav Res Ther 1996;34:621-632.